Meanwhile, spending on vegetables, eggs, nuts and other foods that support GLP-1 balance increased in comparison to non-GLP-1 users and gum, mints and non-chocolate candy also got a boost, presumably to help users battle the side effects of bad breath and dry mouth
coli protects/damages chondrocyte ferroptosis over the gut-joint axis
Future GLP-1 trends: new drugs and therapies on the horizon The future of weight management may soon involve more than current GLP-1s: Amylin mimetics: These compounds mimic another satiety hormone and may complement GLP-1s. Mazdutide: A dual glucagon/GLP-1 agonist showing strong Phase 3 results and promising greater weight loss. Oral GLP-1s: Pills in development could improve convenience. Muscle-preserving combinations: Researchers are exploring co-therapies to prevent loss of lean mass during weight loss. Providers should prepare for a rapidly evolving landscape and educate patients about upcoming options. Key takeaways on GLP-1 trends for providers and patients Efficacy varies across drugs and doses
But TRT operates on one axis
According to the CDC, adults between the ages of 18-64 years old should try and get at least 150 minutes of moderate-intensity exercise per week, while also including some form of strength training exercises to help improve muscle tone and metabolism
Target: 500 mcg daily by Weeks 916